Medication info
Paracetamol Tramadol Extended Release Tablets

Paracetamol Tramadol Extended Release Tablets

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Dong-A ST Co., Ltd.
Appearance
Pale yellow round extended-release film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201506481 · Approved 2015.09.09 · Insurance code 642507270

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the patient’s level of pain and response to treatment. The recommended initial dose is 2 tablets, with subsequent doses given at intervals of at least 12 hours. Do not exceed 8 tablets per day. Do not administer this medicine for longer than necessary. If long-term administration is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment with this medicine; therefore, closely monitor the patient’s response and adjust treatment as appropriate. Elderly: Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when tramadol was administered orally to elderly patients aged 75 years or older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine in patients with renal impairment have not been established; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine in patients with hepatic impairment have not been established; therefore, its use is not recommended.

Ingredients

Manufacturer
Dong-A ST Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medicine is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient’s level of pain and response to treatment. The recommended initial dose is 2 tablets, with subsequent doses given at intervals of at least 12 hours. Do not exceed 8 tablets per day. Do not administer this medicine for longer than necessary. If long-term administration is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment with this medicine; therefore, closely monitor the patient’s response and adjust treatment as appropriate. Elderly: Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when tramadol was administered orally to elderly patients aged 75 years or older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine in patients with renal impairment have not been established; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine in patients with hepatic impairment have not been established; therefore, its use is not recommended.

Precautions

This medication should be discussed with a doctor or pharmacist if the patient consumes alcohol in excess daily, as it may cause liver damage. The acetaminophen component can rarely cause serious skin reactions, so if a rash or hypersensitivity reaction occurs, use should be discontinued immediately. The tramadol included in this medication may increase the risk of seizure in case of overdose, and the risk may be higher if combined with certain antidepressants or other central nervous system medications. Rarely, severe allergic reactions such as anaphylaxis may occur, so any unusual symptoms should be reported to medical personnel immediately. Care should be taken when administering this drug to patients with bronchial asthma due to the risk of respiratory depression; appropriate equipment and monitoring are necessary. Caution should be exercised when combining this medication with alcohol or central nervous system depressants, as severe sedation, respiratory depression, or coma may occur. Patients with brain injuries or elevated intracranial pressure may experience worsening conditions from respiratory depression due to this medication, necessitating caution. The tramadol component may lead to psychological and physical dependence, thus careful observation for dependence is needed during long-term use. Acetaminophen can cause liver damage if overdosed, so it is important to not exceed a total daily dosage of 4,000 mg, and patients with impaired liver function must consult a doctor. Patients with a rapid metabolism of this medication should be closely monitored for respiratory depression as they have a higher risk. This medication should not be used in children under 12 years of age or in certain pediatric patients after surgery, and it is advisable to avoid administering it to adolescents aged 12 to 18 years who may be at risk of respiratory depression. This medication may cause hyponatremia, so patients with risk factors should have their serum sodium levels checked periodically. This medication should not be administered to patients with certain allergies, severe respiratory depression, central nervous system drug abuse, severe liver, kidney, or heart disease, breastfeeding mothers, or children under 12 years of age. Drowsiness or dizziness may occur while taking this medication, so caution is needed when driving or operating hazardous machinery. In case of overdose, respiratory depression, liver damage, and severe toxicity symptoms may occur, so it is crucial to contact a medical institution for appropriate treatment immediately. If this medication is taken for an extended period, dependence or withdrawal symptoms may appear; therefore, dosage should be gradually adjusted per doctor's instructions. Women who are pregnant or may become pregnant should carefully consider the effects of this medication on the fetus, and breastfeeding women should be cautious as this medication can be transferred to the baby through breast milk. Because there are many drug interactions, it is essential to inform a doctor or pharmacist of any other medications being taken, especially caution is required when combined with antidepressants, anticonvulsants, and opioid analgesics.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, stiffness, syncope, withdrawal symptoms, hypertension, exacerbation of hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremors, ataxia, convulsions, hypertonia, migraine, worsening of migraine, involuntary muscle contractions, paresthesia, confusion, dizziness, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting, dysphagia, bloody stools, tongue swelling, appetite loss, anxiety, delirium, euphoria, insomnia, nervousness, drowsiness, forgetfulness, depersonalization, depression, substance abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thinking, anemia, shortness of breath, proteinuria, urinary disturbances, oliguria, urinary retention, pruritus, rash, sweating, urticaria, liver function abnormalities, weight loss, tinnitus, abnormal vision, chills, acrocyanosis, rhinitis, nasopharyngitis, limb pain, joint pain, muscle cramps, muscle weakness, myalgia, blurred vision, conjunctivitis, decreased immune response, sensory abnormalities, stupor, taste abnormalities, involuntary muscle contractions, migraine, dark urine, anuria, urinary hesitancy, urinary incontinence, upper abdominal pain, peptic ulcer, belching, discomfort in the chest, facial swelling, chills, fever, peripheral edema, pallor, blood pressure fluctuations, cough, runny nose, positive urinary erythrocytes, blood pressure increase, palpitations, irregular menstruation, breast cancer, injury, congestive heart failure, vertigo, confusion, speech impairment, loss of consciousness, recurrence of myocardial infarction, hypotension, confusion, multiple organ failure, anaphylaxis, intentional overdose, delirium, miosis, mydriasis, movement disorders, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, thrombocytopenia, agranulocytosis, hepatitis, liver failure, gastrointestinal bleeding, serotonin syndrome, exacerbation of asthma, withdrawal symptoms, delirium, miosis, mydriasis, movement disorders, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, fatigue glutamic acidemia, high-anion-gap metabolic acidosis, vascular relaxation, orthostatic hypotension, bradycardia, collapse, myocardial ischemia, pulmonary edema, respiratory symptoms, bronchospasm, wheezing, angioedema, allergic reactions, changes in appetite, exercise weakness, respiratory depression, cognitive dysfunction, concentration difficulties, suicidal tendencies, emotional changes, activity changes, cognitive changes, sensory ability changes, prolonged prothrombin time, changes in warfarin action, withdrawal symptoms, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, thrombocytopenia, agranulocytosis, high-anion-gap metabolic acidosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid contact with air or moisture, maintaining a storage temperature between 1 and 30 degrees Celsius at room temperature. It is important to avoid direct sunlight or high temperatures and to store it in a place out of reach of children.

Appearance and packaging

Appearance

Pale yellow round extended-release film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.